Thomas Ciulla, MD
Enriched profileRetina Physician, Board Member, Midwest Eye Institute · Midwest Eye Institute
Thomas Ciulla is Retina Physician, Board Member, Midwest Eye Institute at Midwest Eye Institute. OpenAlex indexes 326 publications with 14,128 citations (h-index 63); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the FindMyKOL directory.
Data verified 29 Oct 2026
Overview
Updated 31 Oct 2026
Thomas A. Ciulla, M.D., is Retina Physician, Board Member, Midwest Eye Institute. The public record shows 326 publications with 14,128 citations (h-index 63), centered on Retinal Diseases and Treatments, Ocular Diseases and Behçet’s Syndrome, Retinal and Macular Surgery. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 2 companies.
- Most recent indexed publication: 2026 · Genes
- Top research focus: Retinal Diseases and Treatments
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 31 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 34 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 171.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 31 Oct 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
Sponsor: Clearside Biomedical, Inc.
- Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Sponsor: Clearside Biomedical, Inc.
- Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis
Sponsor: Clearside Biomedical, Inc.
Industry payments
Updated 31 Oct 2026
2 companies reported payments to CMS in program years 2021–2022. These are public disclosures, not judgments. The latest:
- Carl Zeiss Meditec USA, Inc.Program year20221 payment
- Ocular Therapeutix, Inc.Program year20211 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
58.2%Corticosteroid36.4%Prednisolone Acetate100%Part D<11 patientsProstaglandin Analog21.8%Latanoprost100%Part D<11 patientsCardiovascular
41.8%Beta blocker41.8%Timolol Maleate100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 31 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Biological therapies at 25 years: from incremental advances to revolutionary transformations.
Expert opinion on biological therapy
Editorial2026 - Beyond the injection: delivery systems reshaping retinal disease management.
Expert opinion on pharmacotherapy
Review2025 - Autoimmune neuro-ophthalmic disorders: pathophysiologic mechanisms and targeted biologic therapies.
Expert opinion on biological therapy
Review2025 - THREE-YEAR CLINICAL OUTCOMES IN GEOGRAPHIC ATROPHY: An Analysis of 18,712 Patient Eyes.
Retina (Philadelphia, Pa.)
Article2025
Most-cited works
by citation count (OpenAlex)- 01Diabetic Retinopathy and Diabetic Macular EdemaReview835 citations2003
- 02
- 03Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) StudyArticle531 citations2010
- 04Bacterial endophthalmitis prophylaxis for cataract surgeryReview486 citations2002
- 05INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATIONArticle423 citations2000
Network
Updated 31 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 31 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/thomas-ciulla-md-mba-86a5504
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 31 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MBA2015verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗
- M.D.1991verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗
- Board certified
American Board of Ophthalmology
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗
Editorial & leadership roles
journal and society appointments- Adjunct Clinical Professor of Ophthalmology
Indiana University School of Medicine
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗ - Chief Medical Officer
Clearside Biomedical
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗ - President and CEO
Ikarovec
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onenucleus.com ↗ - Honor Award
American Society of Retina Specialists
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗ - Senior Honor Award
American Society of Retina Specialists
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗ - Achievement Award
American Academy of Ophthalmology
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗ - Professor of the Year
Indiana University Department of Ophthalmology
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗ - Career Development Award
Research to Prevent Blindness
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗
Secondary affiliations
appointments beyond the home institution- Clinical Professor / Co-Director of Retina Service
Indiana University School of Medicine (past)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗ - Viridian Therapeutics
Chief Medical Officer (past)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →feeds.buzzsprout.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ois.net ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital